Melatonin and the von Hippel-Lindau/HIF-1 oxygen sensing mechanism: A review

Jerry Vriend, Russel J. Reiter

Resultado de la investigación: Review articlerevisión exhaustiva

54 Citas (Scopus)

Resumen

There are numerous reports that melatonin inhibits the hypoxia-inducible factor, HIF-1α, and the HIF-1α-inducible gene, VEGF, both in vivo and in vitro. Through the inhibition of the HIF-1-VEGF pathway, melatonin reduces hypoxia-induced angiogenesis. Herein we discuss the interaction of melatonin with HIF-1α and HIF-1α-inducible genes in terms of what is currently known concerning the HIF-1α hypoxia response element (HIF-1α-HRE) pathway.The von Hippel-Lindau protein (VHL), also known as the VHL tumor suppressor, functions as part of a ubiquitin ligase complex which recognizes HIF-1α as a substrate. As such, VHL is part of the oxygen sensing mechanism of the cell. Under conditions of hypoxia, HIF-1α stimulates the transcription of numerous HIF-1α-induced genes, including EPO, VEGF, and PFKFB3; the latter is an enzyme which regulates glycolysis. Data from several studies show that ROS generated in mitochondria under conditions of hypoxia stimulate HIF-1α. Since melatonin acts as an antioxidant and reduces ROS, these data suggest that the antioxidant action of melatonin could account for reduced HIF-1, less VEGF, and reduced glycolysis in cancer cells (Warburg effect). A direct or indirect inhibitory action (via the reduction in ROS) of melatonin on proteasome activity would account for much of the published data.

Idioma originalEnglish (US)
Páginas (desde-hasta)176-183
Número de páginas8
PublicaciónBiochimica et Biophysica Acta - Reviews on Cancer
Volumen1865
N.º2
DOI
EstadoPublished - abr. 1 2016

ASJC Scopus subject areas

  • Oncology
  • Genetics
  • Cancer Research

Huella

Profundice en los temas de investigación de 'Melatonin and the von Hippel-Lindau/HIF-1 oxygen sensing mechanism: A review'. En conjunto forman una huella única.

Citar esto